Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.

Simple item page
dc.contributor.authorPotdar, V A
dc.contributor.authorDakhave, M R
dc.contributor.authorKulkarni, P B
dc.contributor.authorTikhe, S A
dc.contributor.authorBroor, S
dc.contributor.authorGunashekaran, P
dc.contributor.authorChawla-Sarkar, M
dc.contributor.authorAbraham, A
dc.contributor.authorBishwas, D
dc.contributor.authorPatil, K N
dc.contributor.authorKadam, A A
dc.contributor.authorKode, S S
dc.contributor.authorMishra, A C
dc.contributor.authorChadha, M S
dc.date.accessioned2015-01-20T11:19:00Z
dc.date.available2015-01-20T11:19:00Z
dc.date.issued2014-08
dc.description.abstractbackground & objectives: Recent influenza antiviral resistance studies in South East Asia, Europe and the United States reveal adamantane and neuraminidase inhibitor (NAIs) resistance. This study was undertaken to evaluate antiviral resistance in influenza viruses isolated from various parts of India, during 2004 to 2011. methods: Influenza viruses were analyzed genetically for known resistance markers by M2 and NA gene sequencing. Influenza A/H1N1 (n=206), A/H3N2 (n=371) viruses for amantadine resistance and A/H1N1 (n=206), A/H3N2 (n=272) and type B (n=326) for oseltamivir resistance were sequenced. Pandemic (H1N1) (n= 493) isolates were tested for H274Y mutation by real time reverse transcription (rRT)-PCR. Randomly selected resistant and sensitive influenza A/H1N1 and A/H3N2 viruses were confirmed by phenotypic assay. results: Serine to asparagine (S3IN) mutation was detected in six isolates of 2007-2008.One dual-resistant A/H1N1 was detected for the first time in India with leucine to phenylalanine (L26F) mutation in Mm2 gene and H274Y mutation in NA gene. A/H3N2 viruses showed an increase in resistance to amantadine from 22.5 per cent in 2005 to 100 per cent in 2008 onwards with S3IN mutation. Fifty of the 61 (82%) A/H1N1 viruses tested in 2008-2009 were oseltamivir resistant with H274Y mutation, while all A/H3N2, pandemic A/H1N1 and type B isolates remained sensitive. Genetic results were also confirmed by phenotypic analysis of randomly selected 50 resistant A/H1N1 and 40 sensitive A/H3N2 isolates. Interpretation & conclusions: Emergence of influenza viruses resistant to amantadine and oseltamivir in spite of negligible usage of antivirals emphasizes the need for continuous monitoring of antiviral resistance.en_US
dc.identifier.citationPotdar V A, Dakhave M R, Kulkarni P B, Tikhe S A, Broor S, Gunashekaran P, Chawla-Sarkar M, Abraham A, Bishwas D, Patil K N, Kadam A A, Kode S S, Mishra A C, Chadha M S. Antiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011. Indian Journal of Medical Research. 2014 Aug;140 (2): 244-251.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/155338
dc.language.isoenen_US
dc.source.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4216499/en_US
dc.subjectAmantadineen_US
dc.subjectdrug resistanceen_US
dc.subjectIndiaen_US
dc.subjectinfluenzaen_US
dc.subjectoseltamiviren_US
dc.subjectreal time reverse transcriptionen_US
dc.titleAntiviral drug profile of human influenza A & B viruses circulating in India: 2004-2011.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijmr2014v140n2p244.pdf
Size:
370.67 KB
Format:
Adobe Portable Document Format
Description:
Original article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Medical Research